Brandes Investment Partners LP Sells 28,890 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Brandes Investment Partners LP decreased its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 3.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 785,174 shares of the company's stock after selling 28,890 shares during the period. Brandes Investment Partners LP owned about 0.91% of Pediatrix Medical Group worth $10,301,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Quest Partners LLC grew its holdings in shares of Pediatrix Medical Group by 25.6% during the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after purchasing an additional 622 shares during the last quarter. Everence Capital Management Inc. grew its holdings in shares of Pediatrix Medical Group by 7.5% during the 4th quarter. Everence Capital Management Inc. now owns 13,840 shares of the company's stock valued at $182,000 after purchasing an additional 960 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after purchasing an additional 1,040 shares during the last quarter. Quarry LP grew its holdings in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after purchasing an additional 1,662 shares during the last quarter. Finally, AlphaQuest LLC grew its holdings in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after purchasing an additional 2,012 shares during the last quarter. Institutional investors own 97.71% of the company's stock.

Remove Ads

Analyst Ratings Changes

MD has been the subject of several analyst reports. UBS Group increased their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a research report on Friday, February 21st. StockNews.com raised shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Truist Financial increased their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research report on Friday, February 21st. Finally, Macquarie started coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They set an "outperform" rating and a $18.00 price target for the company. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Pediatrix Medical Group has a consensus rating of "Hold" and a consensus target price of $17.08.

Pediatrix Medical Group Stock Down 0.8 %

NYSE:MD traded down $0.12 on Thursday, reaching $14.12. 399,599 shares of the stock traded hands, compared to its average volume of 802,736. The company has a market capitalization of $1.21 billion, a price-to-earnings ratio of -11.76, a PEG ratio of 1.74 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The company's fifty day simple moving average is $14.25 and its 200 day simple moving average is $13.48.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.